They both work differently and offer unique benefits
If those first two sound familiar, it's because the current generation of weight loss medications already targets them
Reduced inflammation normalizes endometrial receptivity by rebalancing local estrogen and progesterone signaling, which supports implantation
Semaglutide helps people lose weight and control their blood sugar by releasing the hormone GLP-1, which makes us feel full while eating
While the treatment did not significantly alter early inflammatory responses, it enhanced the resolution of inflammation in the sub-chronic phase, as evidenced by reduced microglial activation in the hippocampus (BH-adjusted P =910 -4 ) and whole brain (BH-adjusted P =0.003
After at least 3 months of treatment, the pooled %TWL was 9.24% for liraglutide, 11.38% for semaglutide, and 15.50% for tirzepatide, with corresponding weight reductions of 8.56 kg, 11.62 kg, and 12.60 kg, respectively